Cohort
|
Outcome
| |
Without 14-3-3η
|
With 14-3-3η
|
---|
≥0.2 ng/ml
|
≥0.4 ng/ml
|
≥0.8 ng/ml
|
---|
Early RA
|
Joint damage status
|
Model LR
|
2.99
|
7.06
|
8.54
|
8.54
|
p
|
0.084
|
0.029
|
0.014
|
0.014
|
R
2
|
0.065
|
0.154
|
0.187
|
0.187
|
Radiographic progression
|
Model LR
|
11.16
|
12.27
|
13.72
|
13.72
|
P
|
0.004
|
0.007
|
0.003
|
0.003
|
R
2
|
0.252
|
0.273
|
0.310
|
0.310
|
Established RA
|
Joint damage status
|
Model LR
|
12.35
|
13.94
|
12.36
|
12.76
|
P
|
0.006
|
0.008
|
0.015
|
0.013
|
R
2
|
0.376
|
0.425
|
0.377
|
0.389
|
Radiographic progression
|
Model LR
|
8.78
|
9.71
|
13.78
|
13.13
|
P
|
0.003
|
0.008
|
0.001
|
0.001
|
R
2
|
0.167
|
0.185
|
0.262
|
0.250
|
- aLR, Likelihood ratio; RA, Rheumatoid arthritis.